HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The synthesis of alpha,beta-unsaturated carbonyl derivatives with the ability to inhibit both glutathione S-transferase P1-1 activity and the proliferation of leukemia cells.

Abstract
Ethacrynic acid (EA), an alpha,beta-unsaturated carbonyl compound, is a glutathione S-transferase P1-1 (GSTP1-1) inhibitor. Twenty-one novel EA derivatives have been synthesized. The effects of these compounds on GSTP1-1 activity and on the proliferation of human leukemia HL-60 cells have been determined. Compounds with a halogen substitution at the 3'-position of the aromatic ring have greater inhibitory effects on GSTP1-1 activity than those of compounds with a methyl substitution there. Compounds with substitutions at both the 2'- and 3'-positions of the aromatic ring have more antiproliferative ability than those with one substitution at 3'-position. Esterification of the carboxyl group appears to increase the antiproliferative ability.
AuthorsGuisen Zhao, Chuan Liu, Rui Wang, Dandan Song, Xiaobing Wang, Hongxiang Lou, Yongkui Jing
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 15 Issue 7 Pg. 2701-7 (Apr 01 2007) ISSN: 0968-0896 [Print] England
PMID17287120 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Glutathione S-Transferase pi
  • Ethacrynic Acid
Topics
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Chromatography, Thin Layer
  • Enzyme Inhibitors (chemical synthesis, pharmacology)
  • Ethacrynic Acid (analogs & derivatives, chemical synthesis, pharmacology)
  • Glutathione S-Transferase pi (antagonists & inhibitors)
  • HL-60 Cells
  • Humans
  • Leukemia (drug therapy)
  • Magnetic Resonance Spectroscopy
  • Spectrophotometry, Infrared
  • Spectroscopy, Fourier Transform Infrared
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: